Preferred Name |
Paromomycin Sulfate |
|
Synonyms |
|
|
Definitions |
The sulfate salt form of paromomycin, a structural derivative of neomycin, an aminoglycoside antibiotic with amebicidal and bactericidal effects against predominantly aerobic gram-negative bacteria. Paromomycin binds specifically to the RNA oligonucleotide at the A site of bacterial 30S ribosomes, thereby causing misreading and premature termination of translation of mRNA and inhibition of protein synthesis followed by cell death. |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C47652 |
|
CAS_Registry |
1263-89-4 |
|
CHEBI_ID |
CHEBI:7935 |
|
Chemical_Formula |
C23H45N5O14.H2SO4 |
|
code |
C47652 |
|
Contributing_Source |
FDA |
|
definition |
The sulfate salt form of paromomycin, a structural derivative of neomycin, an aminoglycoside antibiotic with amebicidal and bactericidal effects against predominantly aerobic gram-negative bacteria. Paromomycin binds specifically to the RNA oligonucleotide at the A site of bacterial 30S ribosomes, thereby causing misreading and premature termination of translation of mRNA and inhibition of protein synthesis followed by cell death. |
|
FDA_UNII_Code |
845NU6GJPS |
|
Has_Free_Acid_Or_Base_Form | ||
in_subset | ||
label |
Paromomycin Sulfate |
|
Legacy Concept Name |
Paromomycin_Sulfate |
|
NCI_Drug_Dictionary_ID |
769609 |
|
NSC Number |
227228 |
|
PDQ_Closed_Trial_Search_ID |
769609 |
|
PDQ_Open_Trial_Search_ID |
769609 |
|
Preferred_Name |
Paromomycin Sulfate |
|
prefixIRI |
NCIT:C47652 |
|
prefLabel |
Paromomycin Sulfate |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0205881 |
|
subClassOf |